AIMS/HYPOTHESIS: Adults with type 2 diabetes mellitus have impaired microvascular function. It has been hypothesised that microvascular function may be restored through regular exercise. The aim of this study was to investigate whether 6 months of regular aerobic exercise would improve microvascular function in adults with type 2 diabetes. MATERIALS AND METHODS:Fifty-nine patients with type 2 diabetes (32 males, age 62.9+/-7.6 years, HbA(1c) 6.8+/-0.9%) were randomised to either a 6-month aerobic exercise programme (30 min, three times a week, 70-80% of maximal heart rate) or a 'standard care' control group. Before and after the intervention period, microvascular function was assessed as the maximum skin hyperaemia to local heating and endothelial and non-endothelial responsiveness following the iontophoretic application of acetylcholine and sodium nitroprusside. Maximal oxygen uptake, as an index of aerobic fitness, was assessed using a maximal exercise test. RESULTS: No significant improvement was seen in the exercise group compared with the control group for any of the variables measured: maximal oxygen uptake (control pre: 1.73+/-0.53 [means+/-SD] vs post: 1.67+/-0.40; exercise pre: 1.75+/-0.56 vs post: 1.87+/-0.62 l/min, p=0.10); insulin sensitivity (insulin tolerance test) (control pre: -0.17+/-0.06 vs post: -0.17+/-0.06; exercise pre: -0.16+/-0.1 vs post: -0.17+/-0.07 mmol l(-1) min(-1), p=0.97); maximal hyperaemia (control pre: 1.49+/-0.43 vs post: 1.52+/-0.57; exercise pre: 1.42+/-0.36 vs post: 1.47+/-0.33 V, p=0.85); peak response to acetylcholine (control pre: 1.37+/-0.47 vs post: 1.28+/-0.37; exercise pre: 1.27+/-0.44 vs post: 1.44+/-0.23 V, p=0.19) or to sodium nitroprusside (control pre: 1.09+/-0.50 vs post: 1.10+/-0.39; exercise pre: 1.12+/-0.28 vs post: 1.13+/-0.40 V, p=0.98). CONCLUSIONS/ INTERPRETATION: In this group of type 2 diabetic patients with good glycaemic control a 6-monthaerobic exercise programme did not improve microvascular function or aerobic fitness.
RCT Entities:
AIMS/HYPOTHESIS: Adults with type 2 diabetes mellitus have impaired microvascular function. It has been hypothesised that microvascular function may be restored through regular exercise. The aim of this study was to investigate whether 6 months of regular aerobic exercise would improve microvascular function in adults with type 2 diabetes. MATERIALS AND METHODS: Fifty-nine patients with type 2 diabetes (32 males, age 62.9+/-7.6 years, HbA(1c) 6.8+/-0.9%) were randomised to either a 6-month aerobic exercise programme (30 min, three times a week, 70-80% of maximal heart rate) or a 'standard care' control group. Before and after the intervention period, microvascular function was assessed as the maximum skin hyperaemia to local heating and endothelial and non-endothelial responsiveness following the iontophoretic application of acetylcholine and sodium nitroprusside. Maximal oxygen uptake, as an index of aerobic fitness, was assessed using a maximal exercise test. RESULTS: No significant improvement was seen in the exercise group compared with the control group for any of the variables measured: maximal oxygen uptake (control pre: 1.73+/-0.53 [means+/-SD] vs post: 1.67+/-0.40; exercise pre: 1.75+/-0.56 vs post: 1.87+/-0.62 l/min, p=0.10); insulin sensitivity (insulin tolerance test) (control pre: -0.17+/-0.06 vs post: -0.17+/-0.06; exercise pre: -0.16+/-0.1 vs post: -0.17+/-0.07 mmol l(-1) min(-1), p=0.97); maximal hyperaemia (control pre: 1.49+/-0.43 vs post: 1.52+/-0.57; exercise pre: 1.42+/-0.36 vs post: 1.47+/-0.33 V, p=0.85); peak response to acetylcholine (control pre: 1.37+/-0.47 vs post: 1.28+/-0.37; exercise pre: 1.27+/-0.44 vs post: 1.44+/-0.23 V, p=0.19) or to sodium nitroprusside (control pre: 1.09+/-0.50 vs post: 1.10+/-0.39; exercise pre: 1.12+/-0.28 vs post: 1.13+/-0.40 V, p=0.98). CONCLUSIONS/ INTERPRETATION: In this group of type 2 diabeticpatients with good glycaemic control a 6-month aerobic exercise programme did not improve microvascular function or aerobic fitness.
Authors: Tien Y Wong; Wayne Rosamond; Patricia P Chang; David J Couper; A Richey Sharrett; Larry D Hubbard; Aaron R Folsom; Ronald Klein Journal: JAMA Date: 2005-01-05 Impact factor: 56.272
Authors: Y Higashi; S Sasaki; S Kurisu; A Yoshimizu; N Sasaki; H Matsuura; G Kajiyama; T Oshima Journal: Circulation Date: 1999-09-14 Impact factor: 29.690
Authors: Alice Schmidt; Johannes Pleiner; Michaela Bayerle-Eder; Günther F Wiesinger; Suzanne Rödler; Michael Quittan; Gert Mayer; Michael Wolzt Journal: Clin Transplant Date: 2002-04 Impact factor: 2.863
Authors: Noyan Gokce; Joseph A Vita; David S Bader; Debra L Sherman; Liza M Hunter; Monika Holbrook; Carol O'Malley; John F Keaney; Gary J Balady Journal: Am J Cardiol Date: 2002-07-15 Impact factor: 2.778
Authors: Daniel J Green; Jennifer H Walsh; Andrew Maiorana; Matthew J Best; Roger R Taylor; J Gerard O'Driscoll Journal: Am J Physiol Heart Circ Physiol Date: 2003-08-21 Impact factor: 4.733
Authors: R Hambrecht; E Fiehn; C Weigl; S Gielen; C Hamann; R Kaiser; J Yu; V Adams; J Niebauer; G Schuler Journal: Circulation Date: 1998-12-15 Impact factor: 29.690
Authors: Colin Farr; Andrew R Middlebrooke; Neil Armstrong; Alan R Barker; Jon Fulford; David M Mawson; Ali M McManus Journal: J Sports Sci Med Date: 2019-08-01 Impact factor: 2.988
Authors: Franciele R Figueira; Daniel Umpierre; Felipe V Cureau; Alessandra T N Zucatti; Mériane B Dalzochio; Cristiane B Leitão; Beatriz D Schaan Journal: Sports Med Date: 2014-11 Impact factor: 11.136
Authors: M Whiteman; K M Gooding; J L Whatmore; C I Ball; D Mawson; K Skinner; J E Tooke; A C Shore Journal: Diabetologia Date: 2010-04-23 Impact factor: 10.122
Authors: V S Sprung; D J Cuthbertson; C J A Pugh; C Daousi; G Atkinson; N F Aziz; G J Kemp; D J Green; N T Cable; H Jones Journal: J Physiol Date: 2013-01-14 Impact factor: 5.182
Authors: Navabeh Zare-Kookandeh; Marjan Mosalman Haghighi; Hassane Zouhal; Ali Daraei; Maysa de Sousa; Mohammad Soltani; Abderraouf Ben Abderrahman; Jed M Tijani; Anthony C Hackney; Ismail Laher; Ayoub Saeidi Journal: Rev Endocr Metab Disord Date: 2021-04-30 Impact factor: 6.514
Authors: J M Jakicic; S A Jaramillo; A Balasubramanyam; B Bancroft; J M Curtis; A Mathews; M Pereira; J G Regensteiner; P M Ribisl Journal: Int J Obes (Lond) Date: 2009-01-20 Impact factor: 5.095